The Role of Biomarkers in Temporomandibular Disorders: A Systematic Review
International Journal of Molecular Sciences · 21.06.2025 · 26 (13) · 5971
DOI: 10.3390/ijms26135971 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.06.2025. Verfasst von Joana Maria Soares und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Unit of Experimental Biology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal. Hauptthemen laut MEDLINE: Temporomandibular Joint Disorders, Biomarkers. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Temporomandibular disorders (TMDs) impact quality of life and present diagnostic and treatment challenges. Biomarkers may serve as an additional tool to support diagnosis and monitor disease progression, offering supplementary information for treatment strategies in specific and selected patients. This systematic review aimed to assess the role of biomarkers in diagnosing TMD and guiding personalized treatment. It also examined key biomarkers linked to chronic temporomandibular joint (TMJ) pain and how therapies affect biomarker levels and clinical outcomes. A comprehensive search was conducted in PubMed, Scopus, and Web of Science to identify observational and interventional studies assessing the role of biomarkers in synovial fluid/tissue, saliva, and blood. The research was registered in PROSPERO, adhered to PRISMA guidelines, and employed Cochrane Risk of Bias tools. To assess the effect, only studies examining biomarker levels were considered. A total of forty-six studies met the inclusion criteria: three randomized controlled trials were rated as having some concerns, as were most of the observational studies. Elevated levels of interleukins (1ß and 6), tumour necrosis factor alpha, and prostaglandin E2 in synovial fluid were correlated with temporomandibular joint (TMJ) inflammation. Increased matrix metalloproteinases (2, 7, and 9) indicated cartilage deterioration, while oxidative stress markers such as malondialdehyde were higher in TMD patients. Treatments including hyaluronic acid, platelet-rich plasma, and low-level laser therapy effectively reduced inflammatory biomarkers and improved symptoms. Biomarkers show potential to contribute to the understanding of pathophysiological mechanisms in TMD and may support future diagnostic and therapeutic strategies for selected patients. After high-quality studies confirm these findings, this approach will enable personalized medicine by tailoring treatments to individual patient profiles, ultimately leading to improved outcomes and quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedicine, Unit of Experimental Biology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
- Rheumatology Service, Unidade Local de Saúde do Alto Minho, Hospital Conde de Bertiandos, 4990-078 Ponte de Lima, Portugal.
- Institute for Research and Innovation in Health and IBMC, University of Porto, 4200-135 Porto, Portugal.
ORCID-Profile: Joana Maria Soares, Bruno Daniel Carneiro, Daniel Humberto Pozza
Zitieren
APA
Soares, J. M., Carneiro, B. D., & Pozza, D. H. (2025). The Role of Biomarkers in Temporomandibular Disorders: A Systematic Review. International Journal of Molecular Sciences, 26(13), 5971. https://doi.org/10.3390/ijms26135971
Vancouver
Soares JM, Carneiro BD, Pozza DH. The Role of Biomarkers in Temporomandibular Disorders: A Systematic Review. International Journal of Molecular Sciences. 2025;26(13):5971. doi:10.3390/ijms26135971
BibTeX
@article{Soares2025,
author = {Soares, Joana Maria and Carneiro, Bruno Daniel and Pozza, Daniel Humberto},
title = {The Role of Biomarkers in Temporomandibular Disorders: A Systematic Review},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {13},
pages = {5971},
doi = {10.3390/ijms26135971}
}
EUVIMED